Drug intelligence / Profile preview

pseudoephedrine

Development stage
Approved
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Pseudoephedrine is a sympathomimetic amine and decongestant used to relieve nasal and sinus congestion caused by colds, allergies, hay fever, or sinusitis. It works primarily as an agonist at alpha adrenergic receptors (and to a lesser extent beta adrenergic receptors), causing vasoconstriction in the nasal mucosa which reduces swelling and congestion. Pseudoephedrine also acts as a norepinephrine releasing agent, indirectly stimulating adrenergic receptors throughout the body. It is taken orally and is available both alone and in combination with other medications for symptomatic relief of upper respiratory tract conditions[1][2][3][4][5].

Brand names
SudafedChlor Trimeton Nasal DecongestantContac ColdDrixoral Decongestant Non-DrowsyElixsure DecongestantEntex
Other names
pseudoephedrine hydrochloride
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)ADRB1 (β1)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on pseudoephedrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pseudoephedrine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call